Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-017735

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
YU Wing Tak Wendy Director 2022-06-16 Grant or award · Stock Option (right to buy) +20,000 20,000 D: show line 1 in the form
Loading xslF345X03/wf-form4_165586062300607.xml…